865 F. Supp. 2d 811
W.D. Mich.2012Background
- Plaintiffs sue on behalf of a class of Stryker stock purchasers alleging securities fraud under Sections 10(b) and 20(a) and Rule 10b-5.
- Regulatory context: Stryker is heavily regulated by the FDA under cGMP; Form 483s and warning letters can trigger regulatory concerns.
- Allegations center on a 20% EPS growth goal funded by cutting quality/regulatory compliance spending, exposing the company to recalls and higher remediation costs.
- Warning letters and FDA inspections began revealing regulatory and quality deficiencies at Cork, Mahwah, and Biotech, and a January 2008 QSIP was announced to address these issues.
- Trident hip recall in January 2008 and ongoing QSIP spending affected earnings and investor expectations; earnings trajectory and projections were challenged.
- Plaintiffs allege that high-level insiders profited from inflated stock prices as the true regulatory costs were hidden.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether the complaint plausibly states a §10(b)/Rule 10b-5 claim. | Plaintiffs contend misrepresentations and omissions regarding quality/regulatory issues and the cost to remediate. | Defendants argue statements were either true, non-actionable puffery, or protected by safe harbor. | Dismissed: claims lack actionable misrepresentations and disclosure duty under the asserted theories. |
| Whether the complaint adequately pleads scienter under PSLRA. | Plaintiffs argue insiders knew or were severely reckless about the true extent of quality/regulatory problems. | Defendants contend QSIP and corrective actions show no strong inference of scienter. | Dismissed: no strong inference of scienter established. |
| Whether loss causation is adequately pled. | Plaintiffs claim a causal link between misstatement/omission and stock decline. | Defendants argue the post-period market downturn and other factors break the link. | Dismissed: plaintiffs fail to show causal connection. |
| Whether §20(a) control person liability survives. | Plaintiffs rely on a primary §10b violation to support control liability. | Without a viable §10b claim, §20(a) liability fails. | Dismissed: §20(a) claim dependent on surviving §10b claim. |
| Whether forward-looking statements fall under PSLRA safe harbor given cautionary disclosures. | Plaintiffs claim safe harbor does not apply due to alleged falsity or lack of meaningful caution. | Defendants argue warnings were meaningful and tailored to risks; 2007-2008 guidance was likely true. | Safe harbor applied; forward-looking statements protected. |
Key Cases Cited
- City of Monroe Emps. Ret. Sys. v. Bridgestone Corp., 399 F.3d 651 (6th Cir. 2005) (duty to disclose requires more than general misstatements; materiality alone not enough.)
- Omnicare, Inc. v. Laborers Pension Fund, 583 F.3d 935 (6th Cir. 2009) (soft vs. hard information; no duty to disclose legal compliance without knowledge of falsity.)
- Sofamor Danek Group, Inc. v. Gass, 123 F.3d 394 (6th Cir. 1997) (hard numbers vs. soft information; general compliance statements may be nonactionable.)
- Tellabs, Inc. v. Makor Issues & Rights Ltd., 551 U.S. 308 (S. Ct. 2007) (establishing standard for pleading a strong inference of scienter.)
- DiLeo v. Ernst & Young, 901 F.2d 624 (7th Cir. 1990) (fraud pleading standards and reliance on differences between statements.)